PGE2, a key factor produced in chronic inflammation and tumor (44), potentiate GM-CSF/IL-6-dependent induction of M-MDSC, their suppressive potential and their capacity to induce the Th2 response in vitro. The gene discussed is IL6; the disease is neoplasm.